PR4 IMPACT OF CLINICALLY MEANINGFUL REDUCTION IN DYSPAREUNIA ON HEALTH-RELATED QUALITY OF LIFE AMONG ENDOMETRIOSIS PATIENTS: A POOLED ANALYSIS OF TWO PHASE III CLINICAL TRIALS

Sanjay K. Agarwal, Ahmed M. Soliman, Robin Pokrzywinski, Karin S. Coyne
In: Value in Health · 2020 · vol. 23 , pp. S328 · doi:10.1016/j.jval.2020.04.1231 · W3028469325
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-08, 2026-08-01 ⓘ

This analysis of two Phase III trials assessed the impact of clinically meaningful dyspareunia reduction on health-related quality of life in endometriosis patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisdyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK